Your browser doesn't support javascript.
SARS-CoV-2 vaccines - the biggest medical research project of the 21st century.
Kurup, Drishya; Schnell, Matthias J.
  • Kurup D; Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA, United States.
  • Schnell MJ; Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA, United States; Jefferson Vaccine Center, Thomas Jefferson University, Philadelphia, PA, United States. Electronic address: Matthias.Schnell@jefferson.edu.
Curr Opin Virol ; 49: 52-57, 2021 08.
Article in English | MEDLINE | ID: covidwho-1213121
ABSTRACT
SARS-CoV-2 has been detected in more than 141 million people and caused more than 3 million deaths worldwide. To reduce the additional loss of millions of lives until natural immunity is reached, researchers have focused on the only known method to stop the COVID-19 pandemic vaccines. The pandemic has propelled high-speed vaccine development, some based on novel technology previously not utilized in the vaccine field. The new technology opens new possibilities and comes with challenges because the long-term performance of the new platforms is unknown. Here we review the current leading vaccine candidates against COVID-19 and outline the advantages and disadvantages as well as the unknowns of each candidate.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Biomedical Research / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Language: English Journal: Curr Opin Virol Year: 2021 Document Type: Article Affiliation country: J.coviro.2021.04.008

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Biomedical Research / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Language: English Journal: Curr Opin Virol Year: 2021 Document Type: Article Affiliation country: J.coviro.2021.04.008